Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate
Hyperlipidemia has been frequently recorded as a side effect of treating HIV patients with protease inhibitors (PI). This study was initiated to analyze the modifications on blood lipids in HIV-patients receiving PI and the safety and efficacy of the treatment with fenofibrate. Total (TC) and HDL-ch...
Main Authors: | Caramelli Bruno, Bernoche Claudia Y.S.M. de, Sartori Ana M. C., Sposito Andrei C., Santos Raul D., Monachini Maristela C., Strabelli Tania, Uip Davi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2001-01-01
|
Series: | Brazilian Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000600007 |
Similar Items
-
Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate
by: Bruno Caramelli, et al. -
Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats
by: Ana Soria, et al.
Published: (2002-01-01) -
Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing
by: Michel Farnier
Published: (2008-10-01) -
Hypolipidemic Effects and Safety of Lactobacillus Reuteri 263 in a Hamster Model of Hyperlipidemia
by: Wen-Ching Huang, et al.
Published: (2015-05-01) -
Anethum graveolens and hyperlipidemia: A randomized clinical trial
by: Mahmoud Mirhosseini, et al.
Published: (2014-01-01)